Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Antilymphocyte Serum × Clear all

Sponsor

Conditions

Leukemia 35 Myelodysplastic Syndromes 34 Leukemia, Myeloid, Acute 29 Lymphoma 27 Leukemia, Lymphocytic, Chronic, B-Cell 27 Lymphoma, Non-Hodgkin 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Hodgkin Disease 23 Multiple Myeloma 22 Lymphoma, Large B-Cell, Diffuse 20 Lymphoma, Mantle-Cell 19 Lymphoma, Follicular 19 Lymphoma, B-Cell, Marginal Zone 19 Myeloproliferative Disorders 18 Lymphoma, Large-Cell, Immunoblastic 16 Burkitt Lymphoma 15 Primary Myelofibrosis 14 Neoplasms, Plasma Cell 14 Leukemia, Myeloid, Accelerated Phase 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Congenital Abnormalities 14 Lymphoma, T-Cell, Cutaneous 13 Graft vs Host Disease 13 Leukemia, Myelomonocytic, Chronic 12 Leukemia, Myeloid, Chronic-Phase 12 Blast Crisis 12 Sezary Syndrome 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Extranodal NK-T-Cell 10 Hematologic Neoplasms 10

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡